Ozempic Lawsuit 2026 | Gastroparesis GLP-1 Drug Claims | TortAdvisor

Hire Leading Ozempic Lawyers: Nationwide Legal Representation for GLP-1 Lawsuits

Ozempic Lawsuit 2026: Gastroparesis & GLP-1 Drug Injury Claims

The Ozempic lawsuit targets Novo Nordisk, Eli Lilly, and other GLP-1 drug manufacturers for failing to adequately warn patients that medications including Ozempic, Wegovy, Mounjaro, and Zepbound can cause severe gastroparesis (stomach paralysis) and cyclic vomiting syndrome. The FDA has required updated GLP-1 drug labeling addressing gastrointestinal risks. If you used an Ozempic-type drug and suffered serious stomach complications, you may qualify for an Ozempic lawsuit settlement.

Use our free settlement calculator to estimate your Ozempic lawsuit value.

What Is Gastroparesis?

Gastroparesis is a chronic digestive disorder where the stomach cannot empty properly, causing severe nausea, vomiting, bloating, abdominal pain, and malnutrition. GLP-1 drugs like Ozempic slow gastric emptying as their intended mechanism of action — but in some patients this becomes severe, permanent gastroparesis even after stopping Ozempic. Plaintiffs in Ozempic lawsuits allege the companies knew about this risk and failed to disclose it adequately.

Who Qualifies for an Ozempic Lawsuit?

  • You used Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Victoza, or another GLP-1 drug
  • You were diagnosed with gastroparesis, cyclic vomiting syndrome, or severe gastrointestinal complications requiring medical treatment
  • You required hospitalization or significant medical intervention due to GLP-1 drug side effects

GLP-1 Drugs Named in Ozempic Lawsuits

Active Ozempic lawsuits involve: Ozempic (semaglutide by Novo Nordisk), Wegovy (semaglutide — weight loss formulation), Mounjaro (tirzepatide by Eli Lilly), Zepbound (tirzepatide — weight loss formulation), Rybelsus (oral semaglutide), Victoza (liraglutide), and Trulicity (dulaglutide).

Related Drug Injury Lawsuits

Ozempic Lawsuit FAQs

How long do Ozempic lawsuits take?

Ozempic lawsuits are in early-to-mid litigation stages as of 2026. The MDL is actively growing with thousands of claims. Cases typically take 3-5 years from filing to resolution through settlement or trial. Filing early ensures you benefit from bellwether trial developments.

Can I file an Ozempic lawsuit if I used it off-label for weight loss?

Yes. Both on-label diabetic patients and off-label weight loss users of GLP-1 drugs who suffered serious gastroparesis may have valid Ozempic lawsuit claims. The duty to warn extends to all foreseeable uses of these medications.

Latest News and Updates for 2026

What You Need To Know About Depo-Provera Lawsuit Settlements in 2026

🗓 Last Updated: May 2026 ✅ Reviewed by: TortAdvisor Editorial Team 📚 Sources: FDA, Federal Court, BMJ, PubMed ⚖️ Topic: Depo-Provera MDL No. 3140 What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 is that no global settlement has been announced, federal cases are centralized in MDL No. 3140, and projected compensation depends heavily on tumor severity, surgery, medical costs, lost income, proof of use, and long-term symptoms. Women are filing Depo-Provera lawsuits after meningioma diagnoses allegedly linked to long-term use of medroxyprogesterone acetate injections. The FDA-approved label now includes a meningioma warning, and the official federal court page confirms the litigation is centralized in the Northern District of Florida before Judge M. Casey Rodgers. Short answer: Estimated Depo-Provera lawsuit settlement values may range from about $100,000 to $1 million+ in projected cases, with the most severe injury claims potentially valued higher. These are estimates only, not guarantees. Table of Contents Key TakeawaysSettlement Estimates Meningioma Risk MDL Status Who May Qualify Related Resources Sources FAQs   Key Takeaways for Depo-Provera Lawsuit Settlements in 2026 What You Need To Know About Depo-Provera Lawsuit Settlements in 2026 starts with the current status: the litigation is active, no global settlement has been announced, and individual case value depends on medical evidence and damages. The strongest claims usually involve long-term Depo-Provera use followed by a documented intracranial meningioma diagnosis. No Global Settlement Yet Depo-Provera litigation remains ongoing. Projected payout ranges are estimates until bellwether trials, court rulings, or settlement negotiations establish clearer benchmarks. MDL No. 3140 Federal cases are centralized in the Northern District of Florida for coordinated pretrial proceedings, but each claimant keeps an individual lawsuit. Medical Proof Matters Injection records, imaging reports, diagnosis records, treatment history, [...]

Damages & Compensation

Use our calculator to estimate potential settlement amounts

Frequently Asked Questions

You don’t pay unless we win.

See If Your Case Qualifies for Financial Recovery

Free confidential Case Review with an ozempic lawsuit expert immediately. Act Now

Please complete short confidential survey to get started

Legal Disclaimer: By clicking the “Submit My Case Evaluation” button, I hereby grant consent to be contacted at the phone number or email address I entered above by Tort Advisor, Help Now, and its partners. I understand this may include an automated calling system, artificial voice, pre-recorded messages, email, or an SMS text message. I consent even if my phone number provided is registered on the Federal or State ‘Do Not Call Registry’. I acknowledge that standard message and data rates may apply. Message frequency varies. Text HELP for help. Text STOP to cancel.

Search for an Injury Attorney in your state: